23:18 , Apr 20, 2017 |  BC Innovations  |  Product R&D

Selectivity suite

Although the small molecule landscape has been largely defined by protein-binding agents, new classes of compounds are emerging that block the formation of specific proteins at the level of their RNA, redefining what constitutes a...
07:00 , Aug 13, 2015 |  BC Innovations  |  Tools & Techniques

Helping Beethoven hear

Little progress has been made in developing therapies for hearing loss that go beyond the temporary and partial solutions provided by hearing aids and cochlear implants, and most company activity is focused on acquired forms...
07:00 , Apr 30, 2009 |  BC Innovations  |  Cover Story

miRNAs sounding better

Hearing loss is a field that has been totally refractory to drug treatment. Now, British and Spanish researchers have converged on microRNA-96, or elements downstream of it, as a potential therapeutic target for treating age-related...